Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.380
-0.190 (-5.32%)
Jul 28, 2026, 1:24 PM EDT - Market open
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $261.28 million as of July 28, 2026. Its market cap has increased by 20.53% in one year.
Market Cap
261.28M
Enterprise Value
149.59M
1-Year Change
20.53%
Ranking
Category
Stock Price
$3.38
ChartMarket Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $261.28M, an increase of 485.05%. That is a compound annual growth rate of 21.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 261.28M | 130.26% |
| Dec 31, 2025 | 113.47M | -53.90% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 292.75M |
| Foghorn Therapeutics | 291.81M |
| Immuneering | 286.61M |
| Fate Therapeutics | 283.24M |
| ALX Oncology Holdings | 279.89M |
| Bicycle Therapeutics | 274.36M |
| Sol-Gel Technologies | 272.96M |
| SAB Biotherapeutics | 271.45M |